GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zyversa Therapeutics ZVSA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

0.00%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Zyversa Therapeutics

Our reporting

We have not reported on Zyversa Therapeutics yet.

Next results

18 Nov 2026

Due on 18 Nov 2026.

Past results

Reported against what analysts expected

13 May 202631 Mar 202619 Nov 202513 Aug 202527 Mar 202514 Nov 2024
Earnings per share-0.22-0.43-2.56-0.46-1.79-2.43
Forecast—-0.30-0.25—-2.73-5.80
Revenue————$26,078—

Key events

  1. 26 Apr 202410-to-1 reverse split
  2. 5 Dec 202335-to-1 reverse split
  3. 13 Dec 20221-to-1 reverse split
  4. 21 Dec 2021Listed

Zyversa Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.